Dr. Valderílio Azevedo

M.D., Ph.D., M.Sc

Master in Internal Medicine-Universidade Federal do Paraná, PhD in Health Sciences-Associate Professor of Rheumatology- Universidade Federal do Paraná. Biopharmaceutical consultant. Participated in development of new therapies in Spondyloarthritis, RA and Lupus, planning regulatory strategies, clinical trials, market access . Participated as a consultant for biologics/biosimilars , trials to demonstrate efficacy and safety, regulatory approval. Member of GRAPPA and ASAS. Member of Americas Health Foundation and of Alliance for Safe Biologics.

BIOSIMILARES: La transición hasta la intercambiabilidad: riesgos y beneficios

Funciones de los biosimilares en el acceso de los pacientes a los tratamientos biológicos